GSK (GSK) AIQ Analysis
GSK scores 71/100 with Smart Score 10/10 and Sharpe 1.78.
AIQ Brief
GSK is currently in a constructive setup with AIQ 71/100 and Smart 10/10 (strong relative) at $58.35. Risk is moderate. Read this as a prioritization signal, then confirm entry quality and sizing with your own risk plan.
Quality is the strongest contributor at 81/100, while Risk is the binding constraint at 50/100. With a 31-point spread, the profile is imbalanced, so patience and entry discipline are more important than speed.
GSK ranks 3/4 in this peer set (71 vs peer average 72.8). On risk-adjusted efficiency, Sharpe is below peer average (1.78 vs 2.32). This helps distinguish true relative leadership from broad sector drift.
Action now: this profile can fit a momentum or growth sleeve if sizing is tied to volatility limits and downside tolerance. Watch for momentum holding above 60, risk staying below 65, and quality remaining stable.
Sharpe is 1.78, indicating strong risk-adjusted return for this snapshot.
| AIQ Component | Score | Signal Read |
|---|---|---|
| Momentum | 77 | Strong trend persistence and positive acceleration. |
| Value | 66 | Valuation appears close to fair value. |
| Quality | 81 | Profitability and consistency profile is strong. |
| Risk | 50 | Risk profile is moderate and manageable. |
| Sentiment | — | Sentiment signal is currently unavailable. |
Current AIQ Read
GSK currently screens as bullish in this model, with stronger factor alignment across momentum, quality, and risk context.
Loading GSK analysis...